Furosemide Dosing in Acute Heart Failure
For acute decompensated heart failure, start with 20–40 mg IV furosemide as a slow bolus (over 1–2 minutes) if the patient is diuretic-naïve, or use a dose at least equivalent to their chronic oral dose if already on loop diuretics, ensuring systolic blood pressure is ≥90–100 mmHg before administration. 1, 2, 3
Initial Dose Selection
- Diuretic-naïve patients or those on ≤40 mg oral furosemide daily should receive 20–40 mg IV bolus administered slowly over 1–2 minutes 1, 2, 3
- Patients on chronic oral diuretics require an initial IV dose that is at least equivalent to their oral daily dose (e.g., if taking 80 mg PO daily, give ≥80 mg IV initially) to overcome diuretic tolerance 1, 2
- Severe volume overload with prior diuretic exposure may warrant starting with 40–80 mg IV based on renal function and severity of congestion 1, 2
Critical Pre-Administration Requirements
Before giving any furosemide dose, verify:
- Systolic blood pressure ≥90–100 mmHg – furosemide worsens hypoperfusion and can precipitate cardiogenic shock in hypotensive patients 1, 2
- Serum sodium >125 mmol/L – severe hyponatremia (<120–125 mmol/L) is an absolute contraindication 1, 2
- Absence of anuria – the patient must have detectable urine output 1, 2
- No marked hypovolemia – assess for signs of volume depletion before administration 1, 2
Dose Escalation Protocol
- If urine output remains <0.5 mL/kg/hour after 2 hours, double the dose but never exceed 160–200 mg per individual bolus 1, 2, 3
- Increase in 20 mg increments every 2 hours until adequate diuresis is achieved 1
- Maximum limits: Do not exceed 100 mg in the first 6 hours or 240 mg in the first 24 hours (though higher doses may occasionally be used with close monitoring) 1, 2
Continuous Infusion vs. Bolus Dosing
Both strategies are equally effective – the European Society of Cardiology gives a Class I, Level B recommendation that diuretics can be given either as intermittent boluses or continuous infusion 2
- Continuous infusion option: After initial 40 mg bolus, infuse at 5–10 mg/hour (maximum rate 4 mg/min) 1, 2
- Continuous infusion may be preferred for patients with significant volume overload, those requiring high doses, or when diuretic resistance develops 1, 2, 4
- Practical advantage of continuous infusion: Provides more stable tubular drug concentrations and may overcome diuretic resistance more effectively than intermittent boluses 1, 4
Evidence Comparison
- A 2014 randomized trial showed continuous infusion (10 mg/hour) produced greater 24-hour diuresis (3705 mL) compared to bolus dosing (3093 mL and 2670 mL for different bolus regimens, p<0.01), though clinical symptom relief was similar across groups 5
- However, continuous infusion was associated with higher rates of hypokalemia (36.3% vs. 13.5% and 8.3%, p<0.01) 5
- A retrospective study of low-dose continuous infusion (<160 mg/24 hours) showed significant increase in urine output (150 vs. 116 mL/hour, p<0.001) without detectable worsening of renal function 4
Essential Monitoring
- Place a bladder catheter to measure urine output hourly and rapidly assess treatment response 1, 2
- Target urine output >0.5 mL/kg/hour as a marker of adequate diuretic response 1, 2
- Check electrolytes (especially potassium and sodium) and renal function within 6–24 hours, then every 3–7 days during active therapy 1, 2
- Monitor blood pressure frequently – both bolus and infusion strategies can cause hypotension 1, 2
- Daily weights targeting 0.5–1.0 kg loss per day 1
Managing Diuretic Resistance
- If adequate diuresis is not achieved after 24–48 hours at standard doses, add a second diuretic class rather than escalating furosemide beyond 160 mg/day 1, 2
- Combination options: Hydrochlorothiazide 25 mg PO, spironolactone 25–50 mg PO, or metolazone 2.5–5 mg PO 1
- Sequential nephron blockade (combining loop diuretic with thiazide or aldosterone antagonist) is more effective than monotherapy escalation 1
Absolute Contraindications Requiring Immediate Cessation
Stop furosemide immediately if:
- Systolic blood pressure drops <90 mmHg without circulatory support 1, 2
- Severe hyponatremia develops (sodium <120–125 mmol/L) 1, 2
- Anuria occurs (no urine output) 1, 2
- Severe hypokalemia develops (potassium <3.0 mmol/L) 1
Common Pitfalls to Avoid
- Do not give furosemide to hypotensive patients expecting hemodynamic improvement – it will worsen tissue perfusion and precipitate shock 1
- Do not under-dose out of fear of worsening renal function – a transient creatinine rise ≤0.3 mg/dL is acceptable in asymptomatic patients, and persistent congestion carries greater risk than mild azotemia 1, 6
- Do not exceed 160 mg/day without adding a second diuretic – higher doses provide no additional benefit due to the ceiling effect 1, 2
- Higher prehospital doses are not harmful – a 2015 study showed patients receiving higher prehospital furosemide doses were actually less likely to experience worsening renal function (adjusted OR 1.49 for each 20 mg decrease, p=0.019) 6